MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Clinical trial NCT06345365 · RECRUITING

Trial details

NCT number: NCT06345365
Sponsor: Zhongnan Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia

Start date: 2024-01-18
Primary completion: 2026-12-31
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.